Leadership Overview
ProPath has 5 executives leading key functions including strategy, operations, marketing, and governance.
Driven by a commitment to diagnostic excellence, ProPath provides comprehensive subspecialty pathology services nationwide, advancing patient care through physician-led expertise and a legacy of innovation.
Driven by a commitment to diagnostic excellence, ProPath provides comprehensive subspecialty pathology services nationwide, advancing patient care through physician-led expertise and a legacy of innovation.
Leadership Roles at ProPath
David Baquerizo - Chief Executive Officer
David Baquerizo, the Chief Executive Officer at ProPath, directs the overarching strategic vision and operational framework for the nationwide pathology practice. Baquerizo guides the organization's expansion and service development, ensuring alignment with ProPath's mission of delivering high-quality, physician-owned diagnostic services. This leadership role involves fostering innovation in pathology and maintaining the highest standards of patient care across all subspecialties. Overseeing key functional areas, Baquerizo ensures efficient resource allocation and drives performance improvements. The Chief Executive Officer's focus remains on strengthening ProPath's market position and enhancing its reputation as a leader in diagnostic pathology. Through strategic partnerships and operational excellence, David Baquerizo champions the company's growth and commitment to physician-led healthcare solutions.
Daniel Maganjo - Co-Founder & Chief Executive Officer
Daniel Maganjo, the Co-Founder & Chief Executive Officer at ProPath, shapes the strategic direction and foundational principles of the pathology practice. Maganjo's leadership is central to ProPath's mission of providing comprehensive, subspecialty pathology services nationwide. This executive guides the company's long-term vision, emphasizing physician ownership and diagnostic integrity. The Co-Founder & Chief Executive Officer's responsibilities include fostering a culture of excellence and innovation within the organization. Daniel Maganjo actively engages in strategic planning to ensure ProPath remains at the forefront of diagnostic advancements and maintains its commitment to superior patient outcomes. This role involves driving sustainable growth and reinforcing the company's established reputation in the healthcare sector.
Brian Hodges - Chief Operating Officer
Brian Hodges, the Chief Operating Officer at ProPath, manages the day-to-day operational execution and efficiency of the nationwide pathology services. Hodges oversees the integration of advanced diagnostic technologies and ensures seamless service delivery across all subspecialties. This leadership position focuses on optimizing laboratory workflows, enhancing turnaround times, and maintaining rigorous quality control standards. The Chief Operating Officer drives operational strategies that support ProPath's growth objectives and commitment to physician-led pathology. Brian Hodges directs teams responsible for laboratory management, logistics, and client support, ensuring a high level of service satisfaction. By streamlining processes and implementing best practices, Hodges strengthens ProPath's capacity to serve its clients effectively and maintain its position as a leading diagnostic provider.
Pat Jenevein - President
Pat Jenevein, the President at ProPath, provides executive leadership and strategic oversight for the organization's governance and long-term development. Jenevein's role emphasizes the physician-owned structure and the delivery of comprehensive subspecialty pathology services nationwide. This position guides the strategic alignment of ProPath's operations with its core mission of advancing diagnostic accuracy and patient care. The President ensures that the company adheres to the highest standards of medical ethics and professional practice. Pat Jenevein collaborates with leadership to foster innovation and maintain ProPath's reputation for excellence in the healthcare sector. This executive leadership drives the strategic initiatives that support ProPath's continued success and its commitment to physician-led pathology.
Rinah Lidonde - Chief Marketing Officer
Rinah Lidonde, the Chief Marketing Officer at ProPath, develops and executes comprehensive marketing strategies to enhance brand visibility and market penetration for the pathology practice. Lidonde oversees all aspects of market engagement, including digital presence, client communications, and strategic outreach initiatives. This role is critical in articulating ProPath's value proposition as a nationwide, physician-owned provider of subspecialty pathology services. The Chief Marketing Officer drives initiatives to attract new clients and strengthen relationships with existing partners. Rinah Lidonde focuses on communicating the company's commitment to diagnostic excellence and innovation. By analyzing market trends and customer needs, Lidonde ensures ProPath's services resonate with healthcare providers and contribute to the company's sustained growth and industry leadership.
Explore Leadership Teams in Healthcare Services
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviours and improve health care management. The company offers physicians the broadest test menu, is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staf
Company Leadership
BioReference is a full service specialty laboratory headquartered in Elmwood Park, NJ. The company provides testing and related services to physicians, clinics, hospitals, long-term care facilities, employers, government units, correctional institutions and more.
Company Leadership
HD
GM
MO
Founded in 1986, Solis Mammography is an independent provider of mammography and breast health services in the country. Their services include Screening, Diagnostics, Breast Ultrasound, Breast Biopsy, and Bone Density. The company is headquartered in Addison, Texas.
Company Leadership



Integrated Diagnostics Holdings (IDH) is a leading consumer healthcare company specializing in diagnostic services across the Middle East and Africa. Founded in 1979, IDH operates a network of diagnostic laboratories and medical testing facilities in Egypt, Jordan, Sudan, and Nigeria under brands including Al Borg, Al Mokhtabar, Biolab, Ultralab, and Echo-Scan. The company offers over 1,400 different diagnostic tests with international accreditations for quality and safety. IDH utilizes a Hub, Spoke and Spike business model for expansion, combining centralized testing facilities with distributed collection centers. The company provides both B2B and B2C healthcare services, supported by mobile applications and call centers for customer convenience. As a publicly traded company on the London Stock Exchange, IDH continues to expand its diagnostic testing services throughout the region.
Company Leadership
NA
HK
